Michael Winlo
Chief Executive Officer en EMYRIA LIMITED .
Fortuna: 18 698 $ al 31/03/2024
Perfil
Michael Winlo is the founder of Cerulean Medical Pty Ltd.
(founded in 2007).
He is currently the Chief Executive Officer, Director & MD at Emyria Ltd., a Non-Executive Director at dorsaVi Ltd.
(starting in 2023), a Director at Linear Clinical Research Ltd., and a Non-Executive Director at Nanoveu Ltd.
(starting in 2023).
Dr. Winlo has an MBA from Stanford University and an undergraduate degree from The University of Western Australia Business School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EMYRIA LTD
0.13% | 08/08/2023 | 485 794 ( 0.13% ) | 18 698 $ | 31/03/2024 |
Cargos activos de Michael Winlo
| Empresas | Cargo | Inicio |
|---|---|---|
| EMYRIA LIMITED | Chief Executive Officer | 03/10/2019 |
| NANOVEU LIMITED | Director/Board Member | 28/03/2023 |
| DORSAVI LTD | Director/Board Member | 25/10/2023 |
| Linear Clinical Research Ltd. | Director/Board Member | 01/10/2019 |
Antiguos cargos conocidos de Michael Winlo.
| Empresas | Cargo | Fin |
|---|---|---|
| Cerulean Medical Pty Ltd. | Founder | - |
Formación de Michael Winlo.
| Stanford University | Masters Business Admin |
| The University of Western Australia Business School | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| DORSAVI LTD | Electronic Technology |
| NANOVEU LIMITED | Electronic Technology |
| EMYRIA LIMITED | Technology Services |
| Empresas privadas | 2 |
|---|---|
| Linear Clinical Research Ltd. | |
| Cerulean Medical Pty Ltd. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Winlo
